Literature DB >> 12230485

Future of icodextrin as an osmotic agent in peritoneal dialysis.

Roberto Pecoits-Filho1, Salim Mujais, Bengt Lindholm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12230485     DOI： 10.1046/j.1523-1755.62.s81.11.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  3 in total

1.  Glucose-based peritoneal dialysis fluids downregulate toll-like receptors and trigger hyporesponsiveness to pathogen-associated molecular patterns in human peritoneal mesothelial cells.

Authors:  Jun Wu; Xiao Yang; Yun-Fang Zhang; Ya-Ning Wang; Mei Liu; Xiu-Qing Dong; Jin-Jin Fan; Xue-Qing Yu
Journal:  Clin Vaccine Immunol       Date:  2010-03-03

Review 2.  Icodextrin: a review of its use in peritoneal dialysis.

Authors:  James E Frampton; Greg L Plosker
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Differences in peritoneal response after exposure to low-GDP bicarbonate/lactate-buffered dialysis solution compared to conventional dialysis solution in a uremic mouse model.

Authors:  M Vila Cuenca; E D Keuning; W Talhout; N J Paauw; F J van Ittersum; P M Ter Wee; R H J Beelen; M G Vervloet; E Ferrantelli
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.